Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anandan Palani

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 useAlexandra Trkola, Shawn E Kuhmann, Julie M Strizki, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and DiabetesAnandan Palani, Andrea R Nawrocki, Federica Orvieto, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2012
The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's diseaseHongmei Li, Jun Qin, Pawan Dhondi, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2014
Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like propertiesDong Xiao, Xiaohong Zhu, Younong Yu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent nicotinic Acid receptor agonist for the treatment of dyslipidemiaJun Qin, Ashwin Rao, Xiao Chen, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Discovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved AspartateRobert E Thompson, Aditya J Desai, Dmitri Pissarnitski, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's DiseaseXianhai Huang, Wei Zhou, Xiaoxiang Liu, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase InhibitorsDerun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters|September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-OncologyMin Lu, Hongjun Zhang, Derun Li, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer ImmunotherapyMatthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 useAlexandra Trkola, Shawn E Kuhmann, Julie M Strizki, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and DiabetesAnandan Palani, Andrea R Nawrocki, Federica Orvieto, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2012
The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's diseaseHongmei Li, Jun Qin, Pawan Dhondi, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2014
Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like propertiesDong Xiao, Xiaohong Zhu, Younong Yu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent nicotinic Acid receptor agonist for the treatment of dyslipidemiaJun Qin, Ashwin Rao, Xiao Chen, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Discovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved AspartateRobert E Thompson, Aditya J Desai, Dmitri Pissarnitski, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's DiseaseXianhai Huang, Wei Zhou, Xiaoxiang Liu, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase InhibitorsDerun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters|September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-OncologyMin Lu, Hongjun Zhang, Derun Li, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer ImmunotherapyMatthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.
Pageof 6